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RESUMEN: La Bioestadística es hoy en día una componente científica 
fundamental de la investigación en Biomedicina, salud pública y servi-
cios de salud. Las áreas tradicionales y emergentes de aplicación inclu-
yen ensayos clínicos, estudios observacionales, fisología, imágenes, y 
genómica. Este artículo repasa la situación actual de la Bioestadística, 
considerando los métodos estadísticos usados tradicionalmente en in-
vestigación biomédica, así como los recientes desarrollos de nuevos 
métodos, para dar respuesta a los nuevos problemas que surgen en 
Medicina. Obviamente, la aplicación fructífera de la estadística en 
investigación biomédica exige una formación adecuada de los bioes-
tadísticos, formación que debería tener en cuenta las áreas emergentes 
en estadística, cubriendo al mismo tiempo los fundamentos de la teoría 
estadística y su metodología. Es importante, además, que los estudian-
tes de bioestadística reciban formación en otras disciplinas biomédicas 
relevantes, como epidemiología, ensayos clínicos, biología molecular, 
genética y neurociencia.
PALABRAS CLAVE: Estadística, Epidemiología, Ensayos clínicos, 
Bioinformática, Programas de formación.
ABSTRACT: The discipline of biostatistics is nowadays a fundamen-
tal scientific component of biomedical, public health and health ser-
vices research. Traditional and emerging areas of application include 
clinical trials research, observational studies, physiology, imaging, 
and genomics. The present article reviews the current situation of 
biostatistics, considering the statistical methods traditionally used 
in biomedical research, as well as the ongoing development of new 
methods in response to the new problems arising in medicine. Clear-
ly, the successful application of statistics in biomedical research 
requires appropriate training of biostatisticians. This training should 
aim to give due consideration to emerging new areas of statistics, 
while at the same time retaining full coverage of the fundamentals 
of statistical theory and methodology. In addition, it is important 
that students of biostatistics receive formal training in relevant bio-
medical disciplines, such as epidemiology, clinical trials, molecular 
biology, genetics, and neuroscience.
KEY WORDS: Statistics, Epidemiology, Clinical Trials, Bionformatics, 
training programs.
1.  BIOSTATISTICS AS A DISCIPLINE
There has been explosive growth in the development of 
statistical methodology over the past several decades. 
Research in medicine and public health has been both a 
beneficiary of this new methodology and a source of new 
problems, to the extent that statistics applied to medical 
research – biostatistics – can nowadays be considered a 
discipline in its own right.
In fact, biostatistics has become a defined branch of sci-
ence that uses an intricate combination of statistics, prob-
ability, mathematics and computing to resolve problems in 
the biomedical sciences. Because research questions in bi-
ology and medicine are diverse, biostatistics has expanded 
its domain to include any quantitative, not just statistical, 
model that may be used to answer these questions. As a 
discipline designed to yield information, biostatistics may 
also be considered as a (highly-developed) branch of medi-
cal informatics, which in turn forms part of the developing 
field of bioinformatics. Consequently, biostatistics draws 
quantitative methods from fields including statistics, op-
erations research, economics, and mathematics in general; 
and it is applied to research questions in fields such as 
public health (including epidemiology, nutrition, environ-
mental health, and health services research), genomics and 
population genetics, medicine, and ecology.
The important role that biostatistics and biostatisticians play 
in the field of medical research has always been widely rec-
ognized by the biomedical community, and today statistics 
applied to medicine can be considered a successful model 
for the introduction of statistics into scientific practice. As 
an indication of its importance, the International Committee 
of Medical Journal Editors (ICMJE, http://www.icmje.org) is 
advised by biostatisticians of recognized prestige like DG 
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Altman, and includes in its “Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals” a series of 
recommendations for the correct application and explana-
tion of statistical methods used. Similarly, the biomedical 
journals of highest prestige –such as The Lancet, the British 
Medical Journal, the Journal of the American Medical Asso-
ciation and the American Journal of Epidemiology –include 
biostatisticians (notably specialists in epidemiology and 
clinical trials) among their associate editors and reviewers. 
In addition, journals of this type typically have a “Theory and 
Methods” section admitting articles about methodology, of-
ten statistical methodology. This situation is spreading to 
other biomedical journals.
Biostatistics has developed enormously in recent years, due 
to continuing advances in diverse biomedical areas and 
fields. For example, new problems in biomedical research 
have led to the development of new statistical method-
ologies that would not otherwise have arisen, and at the 
same time have favoured ingenious adaptations of clas-
sical statistical techniques to new contexts of application 
(DeMets et al., 1994, and Zelen, 2006).
So biostatistics has over the years become a discipline in 
itself, enriching not only medicine but statistics in general. 
We only need to look at the current issues of prestigious 
statistical journals, such as the Journal of the American Sta-
tistical Association, or the Journal of the Royal Statistical 
Society, to see the influence that biostatistics has on new 
statistical methodology. In addition, specialized statistical 
journals like Biostatistics, Biometrics, Biometrika, Statistics 
in Medicine and Statistical Methods in Medical Research 
are considered highly prestigious within statistics, and 
occupy high positions in the Journal Citation Index rank-
ing for the category “Statistics and Probability”. In recent 
years, new journals have appeared in this ranking, such as 
the Biometrical Journal, the Journal of Agricultural Biologi-
cal and Environmental Statistics, Stochastic Environmental 
Research and Risk Assessment (SERRA), and Environmet-
rics, covering applications of statistics in environmental 
sciences and public health. It seems likely that the number 
of journals in this ranking will increase in coming years. 
Finally, it is worth noting the publication by Wiley of the 
8-volume Encyclopedia of Biostatistics (2005), whose edi-
tors are biostatisticians of high repute. This work extends 
and broadens the biostatistical content of Wiley’s highly 
respected Encyclopedia of Statistical Sciences.
2.  WHY IS STATISTICS NECESSARY IN MEDICINE?
As we have noted, the growth of quantitative methods in 
the biomedical sciences has made biostatistics a key com-
ponent in many research areas. Let us here consider why 
two major fields of medical research, namely epidemiology 
and clinical trials, depend on statistics as a fundamental 
tool in the achievement of their goals.
2.1.  Epidemiology
Epidemiology is the study of how often diseases occur, 
and why, in different groups of people. Epidemiological 
information is used to plan and evaluate strategies to 
prevent illness, and serves as a guide for the management 
of patients in whom disease has already developed. Like 
the clinical findings and pathology, the epidemiology of 
a disease is an integral part of its basic description. The 
subject has its own special techniques for data collection 
and interpretation.
The connection between biostatistics and epidemiology 
has always been close. The early epidemiologists were 
physicians interested in the way in which diseases oc-
cur in populations, their causes, and their relationships 
with different medical and non-medical factors. The 
problems tackled by these pioneers were not confined to 
the study of epidemics, but extended to the evaluation 
of therapies. Many were skilled in quantitative reasoning 
and were knowledgeable about the statistical methods of 
their day. Then, from the 1930s on, epidemiology began 
to turn its attention to the study of chronic diseases. It 
became impracticable to use the same prospective re-
search strategies that had been so obviously appropriate 
in the study of infectious diseases. And here it was stat-
isticians, primarily Cornfield and Mantel, who provided 
a rationale for approximately valid inference based on 
case-control data. Biostatisticians became more involved 
in elaborating on the conditions for valid inference, with 
concerns about bias due to possible confounding factors. 
Furthermore, they began exploring other issues related 
to epidemiologic research, such as models –called dose-
response models– for evaluating the effects of possible 
risk factors for disease. These effects are quantified by 
measures of association such as the odds ratio or relative 
risk, i.e. probabilistic concepts that need to be estimated 
appropriately, according to the type of study (case-con-
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trol, cross-sectional, or cohort) used for each particular 
research project.
The variety of statistical methods required in epidemiology 
is immense, and has led to the appearance of numerous 
books dealing with applications of statistics in epidemio-
logical contexts. We should also note that the prestigious 
Encyclopedia of Epidemiologic Methods (Series in Biosta-
tistics), published by Wiley in 2000, dedicates major sec-
tions to the most significant contributions of biostatistics 
to the ongoing advances in epidemiological research.
2.2.  Clinical trials
Clinical trials are an essential part of the medical research 
process. Through clinical trials, scientific discovery can 
lead to better ways of preventing, detecting, and treating 
diseases and medical conditions. Clinical trials are studies 
performed with human subjects to test new drugs or com-
binations of drugs, new approaches to surgery or radio-
therapy, or new procedures to improve disease diagnosis 
or patient quality of life. Most hospitals now take part in 
clinical trials, which are only begun after laboratory stud-
ies have indicated that the new treatment or procedure 
is apparently safe, and that it has the potential to work 
better than existing options.
Recent years have seen a major increase in the impor-
tance of statistics in the field of drug development (Anello, 
1990). Statistics plays an essential part at all stages of the 
clinical trial, from planning, through conduct and interim 
analysis, to final analysis and reporting. The statistician 
will typically devise the randomization schedules, advise 
on sample size, specify criteria for measuring treatment 
differences, and analyse response rates. The statistician 
will generally also be the link with the Independent Data 
Monitoring Committee.
Several emerging and recurrent issues relating to the drug 
development process merit particular mention. Emerging 
issues include ongoing changes to the FDA (Food and Drug 
Administration, http://www.fda.gov) regulatory environ-
ment, increasing internationalization of drug development, 
advances in computer technology and visualization tools, 
and efforts to incorporate meta-analytical methodology. 
Recurrent issues include the continuing development of 
statistical methods for handling subgroups in the design 
and analysis of clinical trials; alternatives to the “inten-
tion-to-treat’ analysis in the presence of non-compliance 
in randomized trials; methodologies to address the mul-
tiplicities resulting from a variety of sources, inherent in 
the drug development process; and methods to assure data 
integrity. These issues pose a continuing challenge to the 
international community of statisticians involved in drug 
development. Moreover, the involvement of statisticians 
with different perspectives continues to enrich the field 
and contributes to improvements in public health. The 
important methodological contributions being made by 
biostatisticians to clinical trials research has led to the 
recent creation of a specific journal, Pharmaceutical Sta-
tistics: having appeared only in 2002, it is already in the 
JCR ranking for Statistics and Probability.
3.  STATISTICAL AREAS OF INTEREST IN MEDICINE
According to Armitage (1995), the areas of statistics that 
have most influenced medical statistics in recent years 
have been generalized linear models (including multiple 
linear regression), survival analysis, categorical data analy-
sis, spatial statistics, and Bayesian methods (in diagnostic, 
epidemiological and clinical trials contexts). Meta-analy-
sis, as a tool for evidence-based medicine, has likewise 
attracted considerable attention in recent years.
In 1994, Altman and Goodman suggested that the follow-
ing new statistical methods were going to play a key role in 
biomedical research over coming years: (i) bootstrap (and 
other computer-intensive methods); (ii) Gibbs sampler (and 
other Bayesian methods); (iii) generalized additive models; 
(iv) classification and regression trees (CART); (v) models 
for longitudinal data (general estimating equations); (vi) 
models for hierarchical data; and (vii) neural networks.
In 1997, Houwelingen likewise suggested that the fu-
ture would be marked by new biomedical applications 
(in epidemiology, historical data on oncological patients 
and their families; in ecology, spatial data); by new phi-
losophies (causal models instead of randomized clinical 
trials; prediction versus prognostic modelling); new mod-
els (graphical chain models, random effects models); new 
computational facilities (with an impact on the other as-
pects); new techniques (graphic techniques, exact meth-
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ods, pseudo-likelihood); and new forms of collaboration 
(databases for meta-analysis, Internet software, Internet 
publications).
Many of the predictions made by Altman, Goodman and 
Houwelingen are already a reality, and many of the new 
statistical techniques they argue for have already been 
applied in studies published in prestigious biomedical jour-
nals. However, while these new methods are already being 
used in biomedical research, not all are being widely used. 
One possible explanation for this situation may be the lack 
of standard software implementing these new techniques, 
so that most biomedical researchers view their practical 
application as difficult. It is certainly clear that new tech-
niques may take some while to find their way into medical 
research, although there is some evidence to suggest that 
the speed of transfer has picked up in recent decades.
4.  SOME RECURRENT AND EMERGING
ISSUES IN BIOSTATISTICS
Modern biostatistics presents a number of challenges in 
terms of both the continuing development of classical 
techniques and the creation of new techniques to re-
solve new problems. In this section we focus first on the 
methodology of survival analysis, as an example of the 
advances being made in classical biostatistics. We then 
turn our attention to various emerging fields that merit 
further research by biostatisticians: specifically bioinfor-
matics, spatial statistics, neural networks, and functional 
data analysis.
4.1.  New issues in survival analysis
In many biomedical fields, time-to-event data must fre-
quently be analysed. In oncology, for example, interest 
typically centres on the patient’s time of survival follow-
ing a surgical intervention. The analysis of this type of 
survival experiment is complicated by issues of censoring 
and truncation (Klein and Moeschberger, 2003). Censoring 
occurs when we do not fully observe the patient’s survival, 
due to death unrelated to the cancer under study, or dis-
appearance from the study for some reason. Truncation 
basically occurs when some patients can’t be observed 
for some reasons related to the survival itself. A common 
example of this is in HIV/AIDS studies of the incubation 
period (i.e. time from infection to disease). In these studies, 
the follow-up starts when the HIV virus is detected and the 
moment of infection is retrospectively ascertained.
Since 1959, the Kaplan-Meier curve has been a well-
known estimator of the survival function, and it is ex-
tensively used in epidemiological and clinical research. 
The classical proportional hazards model of Cox (1972) 
is also widely used whenever the goal is to study how 
covariates affect survival. A generalization of the survival 
process arises when survival is the ultimate outcome but 
intermediate states are identified. In this situation, a se-
quence of events is observed, leading to more than one 
observation per individual. Intermediate states might be 
based on categorical time-dependent covariates such as 
transplantation, clinical symptoms (e.g. bleeding episodes), 
or a complication in the course of the illness (e.g. me-
tastasis), or alternatively on biological markers (like CD4 
T-lymphocyte levels). A classical approach for the analysis 
of data of this type is the timedependent Cox regression 
model (TDCM). Advantages of Cox’s regression model in-
clude its easy interpretability and its availability in the 
majority of statistical packages.
In the 1990s, so-called multi-state models (MSMs) became 
available: these offer a better understanding of the disease 
process, leading to a better knowledge of how the time-
dependent covariate affects the evolution of the disease. 
These modern models have several advantages over Cox’s 
regression model. They offer a better understanding of the 
disease process, providing the hazard for movement out of 
one state into another (i.e. transition intensities), as well 
as many other types of information, including the mean 
time of sojourn in each state, and survival rates for each 
state. Covariates on transition intensities can also explain 
differences in the course of the illness among subjects in 
the population. Notably, MSMs can reveal how different 
covariates affect different transitions, something that is 
not possible with other models like the TDCM. In fact, it is 
very unlikely that the risk of death in patients who have re-
ceived different treatments will be the same. Furthermore, 
the prognostic factors associated with the risk of death 
may differ depending, e.g., on the treatment received.
A considerable literature is nowadays available on the 
analysis of MSMs: see for example the books of An-
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dersen et al. (1993) and Hougaard (2000), and references 
therein. The benefits of using the multi-state approach 
can be readily understood from a recent issue of Sta-
tistical Methods in Medical Research, published in 2002, 
entirely devoted to these models. Despite its potential, 
however, MSM is not used by practitioners as frequently 
as other survival analysis techniques. This is attributable 
to a lack of awareness of the software available, and 
perhaps some lack of understanding of the advantages of 
MSM compared to the simple Cox model. In our opinion, 
MSM approaches are likely to make a major contribution 
to our understanding of complex survival processes, and 
it is thus important to try to promote these approaches 
in the biomedical community, for example by including 
them in university statistics courses, and by developing 
user-friendly software applications.
4.2.  Statistical methods in bioinformatics
A very rapidly emerging influence on biostatistics is the 
ongoing revolution in molecular biology. Molecular biology 
is now evolving towards information science, and is ener-
gizing a dynamic new discipline of computational biology, 
sometimes referred to as bioinformatics. Bioinformatics 
merges recent advances in molecular biology and genet-
ics with advanced statistics and computer science. The 
goal is increased understanding of the complex web of 
interactions linking the individual components of a living 
cell to the integrated behaviour of the entire organism. The 
availability of large molecular databases and the decoding 
of the human genome may allow a scientist to plan an 
experiment and immediately obtain the relevant data from 
the available databases. This is an area in which statisti-
cal scientists can make very important contributions. For 
example, the use of micro-array technology has created 
novel statistical problems that will motivate much new 
biostatistical research. In recognition of this major new 
direction in our field several biostatistics departments 
(mainly in the U.S.) have already been renamed as “Bi-
ostatistics and Bioinformatics” departments.
To date, various computational and statistical methods 
have been developed and applied in bioinformatics. Re-
cently, new approaches based on support vector machines 
(Vapnik, 1995) have been suggested (Ewens and Grant, 
2005). Certainly, bioinformatics is characterized by enor-
mous amounts of data, and a heavy reliance on computing. 
Correspondingly, advances in statistical methods necessary 
for analysis are following closely behind advances in data 
generation methods.
Statistical competence is for example of vital importance 
in transforming the huge amounts of functional genomics 
data into usable knowledge, addressing extremely complex 
biological issues such as (a) the design of cDNA microarray 
experiments (how should the samples be distributed on ar-
rays to get the most accurate results?); (b) the conversion 
of images in datasets (what is the optimal way to grid and 
segment images, to relate spot intensities to background 
intensities, and to normalize intensity data within and 
between arrays); (c) the identification of similar groups of 
samples and/or genes using statistical clustering methods; 
(d) the discrimination between groups of samples or as-
signment of new samples to one of a number of groups, 
using statistical methods for discrimination and classifica-
tion; and (e) the identification of genes that are differen-
tially expressed, based on hierarchical Bayesian inference, 
classification modelling or statistical tests.
As we can see, the statistical methods required by bioin-
formatics present many new and difficult problems for the 
research community. To date, the methods of analyses used 
have been mainly ad hoc, and remain at the development 
stage. It is clear that, to achieve optimal results in bioinfor-
matics, close cooperation between researchers in statistics 
and researchers in genetics, biochemistry, medicine and 
biology is essential. A major forum for multidisciplinary 
publications is the journal Bioinformatics, which currently 
occupies the number-one position in the JCR category 
Statistics and Probability.
4.3.  Spatial statistical methods in health studies
The analysis of the geographical distribution of the in-
cidence of disease and its relationship to potential risk 
factors has an important role to play in various kinds of 
public health and epidemiological study. This general area 
is referred to as “geographical epidemiology”, and four 
broad areas of statistical interest can be identified:
(a)  Disease mapping aims to produce a map of the 
true underlying geographical distribution of disease 
incidence, given “noisy” observed data on disease 
rates. This may be useful in suggesting hypotheses 
ARBOR CLXXXIII 725 mayo-junio [2007] 353-361 ISSN: 0210-1963
725Nº
358
STATISTIC
S IN
 B
IO
M
ED
ICA
L R
ESEA
R
C
H
for further investigation, or as part of general health 
surveillance and the monitoring of health problems: 
for example, in helping to detect the outbreak of a 
possible epidemic, or in identifying significant trends 
in disease rates over time.
(b)  Ecological studies are concerned with associations 
between the observed incidence of disease and 
potential risk factors, as measured on groups rather 
than individuals, the groups typically being defined 
by geographical area. Such studies are valuable in 
investigating the aetiology of disease, and may help 
to identify future lines of research, and possibly pre-
ventative measures.
(c)  Disease clustering studies focus on identifying geo-
graphical areas with a significantly elevated risk of 
disease, or on assessing the evidence of elevated risk 
around putative sources of hazard. Uses include the 
targeting of follow-up studies to ascertain reasons 
for observed clustering in disease occurrence, or the 
investigation of control measures where the aetiology 
of observed clustering has been established.
(d)  Environmental assessment and monitoring is con-
cerned with ascertaining the spatial distribution of 
environmental factors relevant to health, and expo-
sure to them, so as to establish necessary controls or 
take preventative action.
Given the breadth and importance of the concerns in 
geographical epidemiology, it is not surprising that there 
has been considerable interest in this area in recent years. 
Much of this interest has been in the development of rel-
evant statistical methods and techniques, and there is no 
doubt that this particular vein of research has been, and 
continues to be, a fruitful source of interesting statistical 
problems, motivating successful methodological develop-
ments within the discipline. Several issues of major sta-
tistical journals have been devoted to spatial statistical 
methods in health applications (e.g. the American Journal 
of Epidemiology, the Journal of the Royal Statistical So-
ciety, and Statistics in Medicine). There has also been a 
considerable volume of papers in the field published sepa-
rately, in key journals including the American Journal of 
Epidemiology, Biometrics, Biometrika, Environmetrics, the 
Journal of the American Statistical Association, and Statis-
tics in Medicine. In addition, a number of significant recent 
texts have been devoted to this subject area (see Cressie, 
1993; Lawson and Cressie, 2000; Lawson 2006).
Finally, there have been various special initiatives con-
cerned with statistical methods in geographical epidemi-
ology. In particular, a considerable amount of statistical 
work has been conducted under the auspices of other 
agencies with long-term interests in geographical and 
environmental health issues, including the US Centers 
for Disease Control and Prevention (CDC), Environmental 
Protection Agency (EPA), and National Research Centre for 
Statistics and the Environment (NRCSE), as well as the Pan 
American Health Organization (PAHO), the World Health 
Organization (WHO), and various European Community 
government agencies.
4.4.  Neural networks in medicine
Neural networks (NN) approaches in medicine have at-
tracted many researchers, and these approaches have been 
implemented in several biomedical applications (see Ohno-
Machado, 1996), including diagnostic systems, biochemi-
cal analysis, image analysis, and drug development. Neural 
networks, which simulate the function of human neuron 
networks, have potentially useful implementations in 
many applications domains. Unlike human decision-mak-
ers, NNs are of course unaffected by factors like fatigue, 
working conditions and emotional state.
NNs have been applied in various areas of medicine: they 
are widely used in diagnostic systems, for the detection 
of cancer and heart problems, and for the analysis of di-
verse types of medical image (including tumour detection 
in ultrasonograms, classification of chest x-rays, tissue 
and vessel classification in magnetic resonance images, 
estimation of skeletal age from x-ray images, and assess-
ment of brain maturation). NNs are used experimentally to 
model the human cardiovascular system: diagnosis can be 
achieved by building a model of the cardiovascular system 
of an individual and comparing it with the real-time physi-
ological measurements taken from that patient. NNs are 
also used as tools in the development of drugs for treating 
cancer and AIDS.
Neural networks are increasingly being seen as an exten-
sion to general statistical methodology, to be given full 
consideration alongside classical and modern statistical 
methods. Reviews arguing this viewpoint include those of 
Ripley (1993, 1996) and Cheng and Titterington (1994), 
and certainly it is a viewpoint that is being widely ac-
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cepted within the neural networks community. However, 
and in spite of the statistical contributions to date, much 
research work remains to be done in this field, and there 
are a number of interesting open problems. For example, 
it would be of great interest to see the incorporation of 
modern flexible nonparametric regression models like gen-
eralized additive models (Hastie and Tibshirani, 1990), or 
the use of bootstrap inference in this context, and in our 
opinion areas like this merit ongoing research.
4.5.  Functional data analysis and medicine
In recent years, because of technological progress, many 
scientific fields in which applied statistics is involved are 
now measuring and recording continuous (i.e. functional) 
data. Notably, many modern apparatuses allow biomedical 
researchers to collect samples of functional data (mainly 
as curves, though also as images).
Since functional data is presented in curve form, it is 
natural to use the curve as the basic unit in functional 
data analysis. Functional data tend to involve a large 
number of repeated measurements per subject, and these 
measurements are usually recorded at the same (often 
equally spaced) time points for all subjects, and with the 
same high sampling rate. Functionals of these curves, such 
as derivatives and locations and values of extrema, are 
sometimes also of interest. This situation is very common 
is areas of basic medicine like endocrinology, for example 
in studies of hormone levels after different drug doses; or 
in neuroscience, for example in studies to estimate the 
firing rate of a population of neurons, in which the unit of 
study is the firing curve of each individual neuron. Another 
example is in the study of growth curves where more than 
one characteristic of growth is observed, e.g. height and 
lung function. Other examples include continuous moni-
toring of biological functions where the predictor is an 
exogenous or an endogenous variable varying over time.
Functional data analysis is a very recent field of research 
in statistics, and interesting contributions and applications 
may be found in the excellent monographs by Ramsay and 
Silverman (2002), Ramsay and Silverman (2005) and Fer-
raty and Vieu (2006), or a special issue of the journal 
Statistica Sinica appeared in 2004. The diversity of this 
field is highlighted by the wide scope of methodological 
problems involved, from numerous applied scientific dis-
ciplines. Three specific types of problem are of particular 
current interest, in view of their links with nonparametric 
statistics: factorial analysis of functional data, regression 
with functional variables, and curve classification.
The aims of functional data analysis are usually of an 
exploratory nature -to represent and display data in order 
to highlight interesting characteristics, perhaps as input 
for further analysis. However, there may be other aims, 
including estimation of individual curves from noisy data, 
characterization of homogeneity and patterns of variabil-
ity among curves, and assessment of the relationships of 
shapes of curves to covariates.
In spite of the important recent contributions in functional 
data analysis, the development of new tools to deal with 
functional data represents a significant challenge for the 
statistical community. Apart from the books already cited, 
a good starting point for thinking about new lines of 
statistical research and possible applications may be the 
special issue on functional data due to appear soon (2007) 
in the journal Computational Statistics and Data Analysis.
5.  TRAINING BIOSTATISTICIANS
As can be deduced from what we have said so far, the 
successful application of statistics in the biomedical sci-
ences requires professionals with a high-level mathemati-
cal training, and at the same time a good understanding 
of the central issues of the biomedical sciences, including 
medical ethics, and of the systemic constraints of the re-
search process. So a biostatistics professional needs to be 
trained not only in traditional statistical theory and meth-
ods (including special topics such as epidemiology, clinical 
trials and survival analysis), but also in bioinformatics and 
basic biology, as well as in communication and leadership 
skills. The demand on leadership is likely to be even greater 
than in the past, given the central role that biostatistics 
and bioinformatics now play in biomedical research.
Thus, a training programme in biostatistics must by ne-
cessity be interdisciplinary, connecting statistics training 
per se to an understanding of the basics of biomedical 
research. Trainee biostatisticians need to learn basic con-
cepts of epidemiology, clinical trials research, genetics 
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and molecular biology, in order to be able to understand 
biomedical research problems and to make meaningful 
contributions to them. A modern training programme of 
this type, with an emphasis on bioinformatics, statistical 
genetics and computational biology, would profit from 
trainees spending time in biomedical laboratories to gain 
first-hand experience and insight into the nature of the 
real problems faced by these researchers. A major goal 
must be to train students to become independent re-
searchers, advancing the field of statistical research and 
its application to biomedical research, both basic and clini-
cal; and at the same time to be team workers intimately 
involved in the design and data analysis of collaborative 
biomedical projects.
Since many biomedical problems will likely require the 
development of new statistical methods, students should 
be capable of critically reading the theoretical and 
methodological literature in statistics, and of develop-
ing new methods as appropriate for the problems that 
they encounter. Students without such rigorous training 
are unlikely to be able to develop new methods or fully 
understand the strengths and limitations of those meth-
ods developed by others. The traditional component of 
biomedical courses will probably focus on areas of math-
ematical statistics including probability theory, inference, 
resampling methods (e.g. bootstrap), linear regression, 
analysis of variance, generalized linear models, survival 
analysis (including multi-state models), nonparametric 
methods, and data analysis. In addition, new methodolo-
gies like spatial statistics, neural networks, and smoothing 
regression methods (such as generalized additive models) 
are strongly recommended.
As we have noted, in order that biostatisticians can offer 
new statistical methodologies useful for the biomedi-
cal research community (in other words, methods that 
are not already incorporated into standard statistical 
software), they need to be competent at software crea-
tion. It is thus of interest for training programmes to 
include components dealing with relevant programming 
languages, like R, which facilitate the implementation 
of new methods (as well as the adaptation of existing 
methods to new biomedical contexts), and which thus 
help biostatisticians to create user-friendly software 
that can be readily used by researchers without a spe-
cialist statistical training. This is turn will favour the 
more rapid transfer of new statistical methods into the 
mainstream of biomedical research.
Also, since the goal is to train students not only to be 
excellent members of research teams, but ultimately to 
be independent biomedical researchers in their own right, 
students must gain some fundamental knowledge of a 
biological specialty area. This knowledge can be gained 
through formal course work or hands-on laboratory expe-
rience, or indeed by a combination of the two. For example, 
courses for a student focusing on statistical genetics might 
include statistical genetics, human genetics, and popula-
tion genetics, as well as courses on areas of computer 
science like database structures, and bioinformatics.
Concern for the current situation of biostatistics in Spain 
led in 1999 to the organization of a Round Table on Sta-
tistics in Medicine, as part of IVth Congress of the Galician 
Society for the Promotion of Statistics and Operations Re-
search. Under the direction of Professor Guadalupe Gómez, 
this round table constituted an interesting reflection on 
various questions of relevance to the profession of bi-
ostatistics, summarized in a valuable article in the journal 
Questióo (Abraira et al., 2001). Specific issues discussed 
included the need to promote postgraduate courses in bi-
ostatistics, aimed at training biostatisticians of the highest 
rank within Spain. In line with this need, the Department 
of Statistics and Operations Research of the University of 
Santiago de Compostela launched in 2005 a new Master 
in Biostatistics (http://eio.usc.es/pub/master_bio), with the 
aim of training students in modern statistical methods for 
biomedical research, and at the same time giving them a 
solid grounding in the major areas of biomedical research, 
notably epidemiology, clinical trials, genetics and bioin-
formatics.
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